IPSIndian Journal of Pharmacology
Home  IPS  Feedback Subscribe Top cited articles Login 
Users Online : 3024 
Small font sizeDefault font sizeIncrease font size
Navigate Here
  Next article
  Previous article 
  Table of Contents
Resource Links
   Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
   Article in PDF (71 KB)
   Citation Manager
   Access Statistics
   Reader Comments
   Email Alert *
   Add to My List *
* Registration required (free)

In This Article

 Article Access Statistics
    PDF Downloaded120    
    Comments [Add]    
    Cited by others 1    

Recommend this journal

Year : 2004  |  Volume : 36  |  Issue : 3  |  Page : 175-176

Effect of cyclophosphamide pretreatment on hematological indices of Indian Bonnet monkeys

Departments of Physiology, Christian Medical College and Hospital, Vellore - 632 002, India

Correspondence Address:
Departments of Physiology, Christian Medical College and Hospital, Vellore - 632 002, India
[email protected]

How to cite this article:
Mythili M D, Nair S C, Gunasekaran S. Effect of cyclophosphamide pretreatment on hematological indices of Indian Bonnet monkeys. Indian J Pharmacol 2004;36:175-6

How to cite this URL:
Mythili M D, Nair S C, Gunasekaran S. Effect of cyclophosphamide pretreatment on hematological indices of Indian Bonnet monkeys. Indian J Pharmacol [serial online] 2004 [cited 2023 Oct 1];36:175-6. Available from: https://www.ijp-online.com/text.asp?2004/36/3/175/6874

The leucocytes carried along with the transplanted tissue (passenger leucocytes) are important in graft rejection. It should be possible to greatly diminish the immunogenicity of a tissue graft if one can remove passenger leucocytes. Appropriate treatment of a tissue prior to transplantation can afford a marked reduction in its immunogenicity for the host. It is now possible to eliminate or at least reduce tissue immunogenicity by removal of leucocytes from the transplant prior to grafting. It therefore makes good theoretical and practical sense to attempt to alter tissue immunogenicity by treating the tissue to be grafted rather than the recipient.[1]
Cyclophosphamide belongs to the nitrogen mustard subclass of alkylating agents. It is an immunosuppressant that alkylates DNA, thereby interfering with its synthesis and function, particularly in proliferating (also in non-proliferating) lymphocytes. Both B and T cells are affected by cyclophosphamide, although the toxicity produced is greater on B cells than T cells. Consequently, this drug exerts its greatest effect by suppressing humoral immunity. When cyclophosphamide is administered in very large doses, it can result in a specific tolerance to any new antigen to which it is simultaneously exposed.[2]
Normal adult Indian Bonnet monkeys (Macaca radiata radiata) of both sexes, weighing between 2 and 6 kg were used in these experiments. After overnight fasting, about 1 ml of the blood was collected from saphenous vein and mixed thoroughly with the anticoagulant K2 EDTA. Cyclophosphamide (60 mg/kg) was administered intraperitoneally on day 0 and 2 after collecting a blood sample both the days. On day 4 the third blood sample was collected. The hematological indices such as hemoglobin, total leucocyte, differential leucocyte, platelet and reticulocyte were estimated. Hemoglobin was estimated by the Cyanmeth hemoglobin method with drabkins solution and a photoelectric calorimeter. Total leucocyte count and platelet counts were done manually by the bulk dilution method using Turk's and platelet diluting fluid (formal citrate) respectively. Reticulocyte count was done manually by a supravital staining at 370C for 20 min with Brilliant cresyl blue dye. Blood smears made were stained by the Leishman's stain and differential leucocyte count done. All the blood samples were also duplicated on an automated cell counter with five-part differential capacity (coulter MAXM) and a good correlation was demonstrated.
Totally, ten monkeys were used for this study. The statistical significance was determined using paired 't' test and P<0.05 was considered significant. In [Table - 1], the change in the hemoglobin levels, platelet, reticulocyte and total leucocyte counts are shown. There was a slight but insignificant fall in the hemoglobin level and platelet count after two days and four days of treatment compared to pre-treatment values. There was no change in the reticulocyte count after two days of treatment but there was a significant fall four days after treatment.
Cyclophosphamide is expected to have more effect on the lymphoid tissues. To find out this effect, total leucocyte and differential leucocyte count were done. There was an insignificant reduction in the total leucocyte count two days after treatment; on the other hand there was a significant marked fall four days after treatment when compared to pre-treatment and two days post-treatment values. There was a significant increase in the percentage of neutrophils four days after treatment. There was no change in the percentage of lymphocytes two days after treatment, whereas there was a significant fall four days after treatment.
The percentage of and basophils had fallen two days after treatment, but came to the pretreated value four days after treatment. In the case of monocytes there was a slight increase after 2 days, but it came to the pretreated value four days after treatment [Table - 2].
In rats cyclophosphamide has an immunotoxic effect on lymphocytes in the spleen and blood. It has also been reported that cyclophosphamide pretreatment in rats sharply decreased the activity of all lymphoid cells, especially the CD4+ lymphocytes.[3] It was reported that both, destruction of donor antigen stimulated T cells in the periphery, and intrathymic clonal elimination of donor reactive T cells, were essential mechanisms of cyclophosphamide-induced tolerance.[4] Cyclophosphamide pretreatment reduces the lymphocytes in the spleen and in blood. The reduction in the activity of the lymphoid tissue by cyclophosphamide could be the reason for a decrease in the lymphocytes in the peripheral blood of the monkeys.

  Acknowledgements Top

This work was supported by grants from Prof. M. Viswanathan Research Grant, Diabetes Research Center, Chennai, and FLUID Research Fund, CMCH. We gratefully acknowledge the help of Mr. Surander Singh and Miss. Rebecca for their help in counting and processing. We thank Mr. Y. Samuel for the maintenance of the monkeys. 

  References Top

1.Lafferty KJ, Woolnough JA. The origin and mechanism of the allograft reaction. Immunol Rev 1977;35:231-62.  Back to cited text no. 1    
2.Lake DF, Akporiaye ET, Hersh EM. Immunopharmacology. In: Katzung BG, editor. Basic and Clinical Pharmacology. 8th ed. New York: Mc Grew Hill; 2001. p. 973-4.  Back to cited text no. 2    
3.Ben-Hur H, Kossoy G, Zndbank J, Zusman I. Response of the immune system of mammary tumor bearing rats to cyclophosphamide and soluble low molecular-mass tumor-associated antigens: rate of lymphoid infiltration and distributions of T lymphocytes in tumors. Int J Mol Med 2002;9:425-30.  Back to cited text no. 3    
4.Eto M, Mayumi H, Tomita Y, Yoshikai Y and Nomoto K. Intrathymic clonal deletion of Vb6+ T cells in cyclophosphamide-induced tolerance to H-2-compatible, Mls-disparate antigens. J Exp Med 1990;171:97-113.  Back to cited text no. 4    
Print this article  Email this article


Site Map | Home | Contact Us | Feedback | Copyright and Disclaimer | Privacy Notice
Online since 20th July '04
Published by Wolters Kluwer - Medknow